Trial Profile
Study of the Efficacy of Maintenance Therapy Using UFT or BCG for the Prevention of Recurrences of Superficial Bladder Cancer Conducted by the Urological Oncology Council of Northern Tokyo.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Dec 2019
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary) ; BCG
- Indications Bladder cancer
- Focus Therapeutic Use
- Acronyms EMBARK
- 12 Mar 2010 New trial record